Antibiogram of clinical isolates from a hospital in Nigeria

African Journal of Biotechnology

Volumn 7, Issue 24, 2008, Pages 4359-4363

  Chikere, C B ^a   Chikere, B O ^b   Omoni, V T ^a  

^a UNIVERSITY OF PORT HARCOURT   (Nigeria)

^b FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Antibiogram; Clinical isolates; Gram negative bacteria; Gram positive bacteria; Nosocomial; Port Harcourt

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AMPICILLIN PLUS CLOXACILLIN; CEFALEXIN; CIPROFLOXACIN; FLUCLOXACILLIN; GENTAMICIN; LINCOMYCIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

AIR SAMPLING; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FOMITE; GOVERNMENT; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; NIGERIA; NONHUMAN; PEDIATRIC WARD; PROTEUS; PUBLIC HOSPITAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; SURGICAL WARD; WARD;

BACILLI (CLASS); BACILLUS CEREUS; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS;

EID: 58149236860     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Buhlmann M, Bogli-Stuber K, Droz S, Muhlemann K (2008). Rapid screening for carriage of methicillin-resistant Staphylococcus aureus by PCR and associated costs. J. Clin. Microbiol. 46(7): 2151-2154.
2. rd ed. Tropical Health Technology and Butterworth London.
3. Cloete TE (2003). Resistance mechanisms of bacteria to antimicrobial compounds. Int. Biodeteriol. Biodegrad. 51: 277-282.
4. Courvalin P, Weber JT (2005). Antimicrobial drugs and resistance. Emerg. Infect. Dis. 11: 791-797.
5. Coyle MB (2005). Manual of Antimicrobial Susceptibility Testing. Am. Soc. Microbiol. Press, Washington D.C. pp 25, 39.
6. Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P (2007). Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20(1): 79-114.
7. Department of Microbiology (2004). A Manual of Laboratory Exercises for Introductory and General Microbiology. University of Port Harcourt Press, Port Harcourt. pp. 19-23.
8. Emori TG, Gaynes RP (1993). An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6(4): 428-442.
9. Esposito S, Leone S (2007). Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious diseases specialist. Int. J. Antimicrob. Agents 29: 494-500.
10. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007). Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob. Agents Chemother. 51(8): 3026-3029.
11. Lewis JS, Herraera M, Wickes B, Patterson JE, Jorgensen JH (2007). First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. healthcare system. Antimicrob. Agents Chemother. 51: 4015-4021.
12. Lockhart SR, Abramson MA, Beekman SE, Gallagher G, Riedel SR, Diekma DJ, Quinn JP, Doern GV (2007). Antimicrobial resistance among Gram-negative bacilli as causes of infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45: 3352-3359.
13. Mendonca N, Leitao J, Manageiro V, Ferreira E (2007). the Antimicrobial Resistance Surveillance Program in Portugal, and Canica, M. (2007). Spread of extended spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob. Agents Chemother. 51(6): 1946-1955.
14. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS (2006). Prevalence of newer β-lactamases in Gram-negative clinical isolates collected in the United States from 2001 to 2002. J. Clin. Microbiol. 44: 3318-3324.
15. Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Christianson S, Simor AE, Paton S (2004). The Canadian Hospital Epidemiology Committee of the Canadian Nosocomial Infection Surveillance Program, Health Canada (2004). Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48: 1204-1214.
16. Piddock LJV (2006). Clinically relevant chromosomally encoded multi drug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19(2): 382-402.
17. Pitout JDD, Nordman P, Laupland KB, Poirel L (2005). Emergence of Enterobac- teriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56: 52-59.
18. th ed. McGraw-Hill, New York, pp. 833-842.
19. Rhomberg PR, Fritsche TR, Sader HS, Jones RN (2006). Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from meropenem yearly susceptibility test information collection program (USA). Diagno. Microbiol. Infect. Dis. 56: 57-62.
20. Singh A, Goering RV, Simjee S, Foley SL, Zervos MJ (2006). Application of molecular techniques to the study of hospital infection. Clin. Microbiol. Rev. 19(3): 512-530.
21. Turnidge J, Paterson DL (2007). Setting and revising the antibacterial susceptibility breakpoints. Clin. Microbiol. Rev. 20(3): 391-408.
22. Villain-Guillot P, Gualtieri M, Bastide L, Leonetti JP (2007). In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm. Antimicrobiol. Agents Chemother. 51(9): 3117-3121.
23. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J (2008). The Canadian Antimicrobial Resistance Alliance (CARA), and Hoban DJ (2008). Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CANICU) study, 2005-2006. Antimicrobiol. Agents Chemother. 52: 1430-1437.